Abstract:Coexistence of nephrotic syndrome and neoplasm is rarely observed in children. We report the diagnostic and therapeutic problems of a 16-year-old female with nephrotic syndrome, ovarian tumor, and increased levels of tumor markers. She was suspected to have paraneoplastic nephrotic syndrome. After ovarian tumor resection, the nephrotic syndrome remission was not observed, while increased tumor marker levels were noted. The patient's final diagnosis was nephrotic syndrome in the course of primary mesangial prol… Show more
“…Remission of paraneoplastic nephrotic syndrome was described at various times after the resection of tumors, which is connected with immunological dysregulation in the course of neoplastic disease [8]. In terms of ovarian malignancies associated with the NS, only few cases of ovarian tumor, mostly in ademocarcinoma type, presenting as nephrotic syndrome have been reported (Table 2) [2,6,9-19]. Nephrotic syndrome seems to occur irrespective to the ovarian tumor diagnostic time, either before (n=6, from 1 to 32 months), during a relapse 2 years after the first diagnosis (n=1), or simultaneously (n=5).…”
We describe a patient who developed nephrotic syndrome in the setting of ovarian tumor. A kidney biopsy showed minimal change nephropathy (MCN). CT scan and MR imaging followed by surgery lead to diagnostic of ovarian dermoid cyst. Surgery combined with corticosteroids resulted in a complete remission of nephrotic syndrome with disappearance of proteinuria after 3 weeks. Ten other cases of ovarian tumor associated with glomerulopathy are reviewed. This is the second case of an ovarian teratoma associated with MCN. Accurate history, physical examination, laboratory data, and kidney biopsy are highlighted in establishing the correct diagnosis in such patients.
“…Remission of paraneoplastic nephrotic syndrome was described at various times after the resection of tumors, which is connected with immunological dysregulation in the course of neoplastic disease [8]. In terms of ovarian malignancies associated with the NS, only few cases of ovarian tumor, mostly in ademocarcinoma type, presenting as nephrotic syndrome have been reported (Table 2) [2,6,9-19]. Nephrotic syndrome seems to occur irrespective to the ovarian tumor diagnostic time, either before (n=6, from 1 to 32 months), during a relapse 2 years after the first diagnosis (n=1), or simultaneously (n=5).…”
We describe a patient who developed nephrotic syndrome in the setting of ovarian tumor. A kidney biopsy showed minimal change nephropathy (MCN). CT scan and MR imaging followed by surgery lead to diagnostic of ovarian dermoid cyst. Surgery combined with corticosteroids resulted in a complete remission of nephrotic syndrome with disappearance of proteinuria after 3 weeks. Ten other cases of ovarian tumor associated with glomerulopathy are reviewed. This is the second case of an ovarian teratoma associated with MCN. Accurate history, physical examination, laboratory data, and kidney biopsy are highlighted in establishing the correct diagnosis in such patients.
“…NS associated with malignancies is uncommon but well documented, with membranous nephropathy being the most common histologic finding seen in patients with solid tumors and MCD seen more commonly in association with Hodgkin Lymphoma 4 . The literature documents 4 cases of mature teratomas associated with NS, and all 4 cases were associated with ovarian mature teratomas 4–7 . The earliest case published in 1989 describes a 7 year-old female who presented with NS refractory to steroids.…”
Section: Observationsmentioning
confidence: 99%
“…4 The literature documents 4 cases of mature teratomas associated with NS, and all 4 cases were associated with ovarian mature teratomas. [4][5][6][7] The earliest case published in 1989 describes a 7 year-old female who presented with NS refractory to steroids. She was ultimately found to have an ovarian mass proven to be mature teratoma.…”
Section: Observationsmentioning
confidence: 99%
“…The last case describes a 16-year-old female with NS and ovarian mature teratoma. Renal biopsy showed mesangial proliferative glomerulonephritis, which responded to tumor resection and cyclosporine 5 …”
A 12-year-old female presented with weight gain, edema, and shortness of breath. Laboratory and urine studies confirmed nephrotic syndrome and presence of a mediastinal mass, identified as a mature teratoma after resection. Nephrotic syndrome persisted despite resection and renal biopsy confirmed minimal change disease, which ultimately responded to steroid treatment. She had two relapses of nephrotic syndrome after vaccination administration, both of which occurred within eight months of tumor resection and were responsive to steroids. Autoimmune and infectious workup for other causes of nephrotic syndrome was negative. This is the first reported case of nephrotic syndrome associated with mediastinal teratoma.
“…A variety of tissues including the stomach, colon, gall bladder, pancreas, bronchial tree, endometrium, salivary glands and prostate express this marker in normal conditions. [1][2][3] Elevated concentrations of CA19-9 has been reported in nonmalignant conditions such as diabetes mellitus, hepatobiliary or pancreatic complications as well as pulmonary diseases. [4][5][6] Elevation of serum and urinary CA19-9 concentrations has also been reported in several benign urological conditions associated with urinary tract obstruction and hydronephrosis.…”
This study was designed to evaluate the role of urinary and serum carbohydrate antigen 19-9 (CA19-9) as a biomarker in the assessment of patients with ureteral stone. A total of 38 patients with ureteral stone and hydronephrosis who underwent transurethral lithotripsy (TUL) (Group A) and 24 age-matched healthy controls (Group B) were evaluated in this study. Urinary and serum CA19-9 concentrations were measured in group A patients before TUL as well as 4 and 8 weeks following the operation. Urinary and serum CA19-9 concentrations were also measured in group B participants. Median concentration of urinary and serum CA19-9 was 34.0 and 15.0 kU/L in group A patients and 16.1 and 5.3 kU/L in group B, respectively (p < 0.001). Medians of CA19-9 concentration in urine and serum reduced to 12.5 and 4.5 kU/L 8 weeks after TUL (p < 0.001). Following successful TUL and hydronephrosis resolution, a significant decline was detected in serum and urinary CA19-9. We also noted that duration of ureteral obstruction was associated with serum and urinary CA19-9 concentrations, suggesting the potential role of this marker in predicting renal damage associated with urinary tract obstruction and determining the appropriate timing of interventions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.